Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective (Q35648485)

9 August 2017

1 reference

title

Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective (English)

1 reference

9 August 2017

1 reference

James T Lane

1

1 reference

9 August 2017

1 March 2004

1 reference

American Journal of Physiology - Renal Physiology

9 August 2017

1 reference

9 August 2017

286

1 reference

9 August 2017

3

1 reference

9 August 2017

F442-50

1 reference

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

9 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Type 2 diabetes in children: clinical aspects and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Changes in bone mineral content with decreased training in competitive young adult tennis players and controls: a prospective 4-yr follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Puberty decreases insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Direct hemodynamic effect of insulin in the isolated perfused kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Increasing prevalence of Type II diabetes in American Indian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Two-photon excitation imaging of pancreatic islets with various fluorescent probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Association between adiponectin and mediators of inflammation in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Effect of fatty acids on glucose production and utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Non-insulin-dependent diabetes mellitus in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Establishing surveillance for diabetes in American Indian youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Testing for microalbuminuria in 2002: barriers to implementing current guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Features of endothelial dysfunction in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Microalbuminuria in the US population: third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Prevention of fat-induced insulin resistance by salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

The changing natural history of nephropathy in type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Diabetic kidney disease: impact of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Variations in the Pattern of Pubertal Changes in Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Variations in pattern of pubertal changes in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Pubertal changes in insulin secretion and peripheral insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Nephropathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Regional differences in albuminuria among American Indians: an epidemic of renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Emerging epidemic of type 2 diabetes in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Diabetes and cardiovascular disease. The "common soil" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

C-reactive protein is associated with renal function abnormalities in a non-diabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Androgens and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00247.2003

10.1152/AJPRENAL.00247.2003

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14761931